---
title: "Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick disposes of 10,250 common shares worth $446,862.08"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291975794.md"
description: "Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick exercised options for 10,250 shares at $6.11 and sold them the same day at an average of $43.60 on July 6, 2026. The transaction was valued at approximately $446,862. She retains 40,685 stock options and holds no directly reported shares post-transaction."
datetime: "2026-07-07T20:38:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291975794.md)
  - [en](https://longbridge.com/en/news/291975794.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291975794.md)
generator: "portal-rs"
---

# Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick disposes of 10,250 common shares worth $446,862.08

-   Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick exercised stock options for 10,250 shares at USD 6.11 on July 6, 2026. \* Fitzpatrick sold 10,250 shares the same day at an average USD 43.6, leaving no directly held shares reported. \* She reported 40,685 stock options remaining after the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002061851-26-000006), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SION.US](https://longbridge.com/en/quote/SION.US.md)

## Related News & Research

- [22:22 ETRobbins LLP Reminds Stockholders it is Investigating the Recent Stock Drop of Sionna Therapeutics](https://longbridge.com/en/news/296425061.md)
- [SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law](https://longbridge.com/en/news/296031680.md)
- [Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram disposes of 404 common shares worth $20,159.6](https://longbridge.com/en/news/296531261.md)
- [Protagenic Therapeutics executive chair Garo H. Armen acquires 2,700 common shares for $945](https://longbridge.com/en/news/296498804.md)
- [Dianthus Therapeutics director Simon Read disposes of common shares worth $326,148.9](https://longbridge.com/en/news/296405573.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**